Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.
about
The Akt-associated microRNAsTumor suppressor microRNAs: a novel non-coding alliance against cancermiR-145 inhibits isoproterenol-induced cardiomyocyte hypertrophy by targeting the expression and localization of GATA6Regulation of microRNAs by natural agents: new strategies in cancer therapies.SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repressionMicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways.MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factorBasal and stress-inducible expression of HSPA6 in human keratinocytes is regulated by negative and positive promoter regionsExosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway.C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma.MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets.Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182.COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilizationTargeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients.Regulation of androgen receptor splice variant AR3 by PCGEM1Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiencyDirect, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.Effects of dietary phytophenols on the expression of microRNAs involved in mammalian cell homeostasis.Mechanisms of miR-145 regulating invasion and metastasis of ovarian carcinoma.Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145.Inhibition of serotonin transporter expression by C/EBPβ in LPS-activated macrophage cells (HD11).C/EBPβ LIP augments cell death by inducing osteoglycin.MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma.Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance.Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells.Prognostic role of microRNA-145 in various human malignant neoplasms: a meta-analysis of 18 related studies.Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.Transcription factor CCAAT/enhancer-binding protein-β upregulates microRNA, let-7f-1 in human endocervical cells.Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives.miR-145 Antagonizes SNAI1-Mediated Stemness and Radiation Resistance in Colorectal Cancer.
P2860
Q26830734-99BCBCD0-C9D8-4903-9086-89E536D1A8F3Q26995383-4C8C233F-ABF5-4F04-90A8-DEF52AE3E1D4Q28565449-B2B40073-77D7-46D9-AA92-CD4E11AD33F3Q34194495-13FAE717-E94B-4F46-AF39-8AF96EB14934Q34459629-9CED242F-0851-440A-9F20-D1FC09AE1378Q34571491-61D0D532-0FFA-4082-A38C-4266A5581757Q34579942-6AA7ACB5-C9C1-48E5-B040-0EC621C4FCD9Q34629044-93F6EEEE-7DAA-430A-938E-3EB38A434364Q34645569-FBDB7EA3-906B-4897-90CF-3349D256B723Q35067955-CAE47E57-AC6D-42F4-93F0-79A1189A56C3Q35677900-B07A2C6B-1FCD-45C3-BE30-A54012D5E671Q35923419-893489D7-844B-403D-AF99-83FDA4EA9736Q36012772-7422EED6-E49C-426D-B1EC-A71A437E02D0Q36140097-BEF78970-2C96-44F7-9E4C-B7B3B5A7B741Q36145645-3A49B4DE-B2DE-4C8E-A3EA-30974177485AQ36414284-FCFFFAD7-B585-44D2-A692-3D07E245E95BQ36738971-3EC7A2EF-AF12-44D1-A44F-6E08815A0D2CQ36785112-787E2BA5-EE42-4E39-B9E0-3F017EAD395DQ36959130-BAF8DACC-2FE8-4FA8-A9FE-EE3416A91506Q37085800-58FB6182-E6C6-4C57-B639-B91ECAA9702EQ37305250-5573C2FC-7718-4AD2-9DCC-93CE201961F1Q37547206-8356358A-7F69-4575-A5FF-CCBA43701978Q38106928-3AB88181-7D5A-4344-B237-3859E7C159B9Q38643149-9E4B4342-5D89-4DBE-A70A-92DB779F6CD2Q38715437-1C774522-4ED7-4CF8-AAEF-E4AFC310B641Q38957350-DB0A9701-6F19-4DFC-A3FD-37D9C7A178DEQ41698596-1E6A260A-6F9B-4EC7-BFA9-0B96248F1ACCQ41901440-6FAB7905-DB79-4766-B815-02951AE8DDCAQ42180647-EB5E2877-E605-47D9-96DE-B3416750F1A3Q42417341-25DF1C4C-DE5E-4723-8739-4C444BFBD70FQ43046143-5438E7FE-DCC3-4D40-B64B-39AF1338C504Q46133698-361E44DC-70A5-44DC-B727-2DD29ED237BFQ47786274-688B77CE-8993-48D7-9744-363FA9F3827CQ48297415-96B5E6A9-635D-474D-9EA7-AEA49A6F2B6EQ52687810-2D401D98-9116-47FD-9CC4-25AC59C1CDC3
P2860
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.
@ast
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.
@en
type
label
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.
@ast
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.
@en
prefLabel
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.
@ast
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.
@en
P2093
P2860
P356
P1476
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.
@en
P2093
Mohit Sachdeva
Yin-Yuan Mo
Zhaohui Lu
P2860
P304
P356
10.1093/NAR/GKS324
P407
P577
2012-04-11T00:00:00Z